We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Clamp-Free Anastomosis Device for Vein Grafts

By HospiMedica International staff writers
Posted on 29 Sep 2008
An innovative handheld device creates an anastomosis between a vein graft and the aorta during coronary artery bypass graft (CABG) surgery, without conventional sutures or the need for arterial clamping.

The PAS-Port proximal anastomosis system is a fully automated device used to join a saphenous vein and the aorta during either on- or off-pump CABG surgery. More...
The system is designed to allow the surgeon to load the bypass graft and rapidly complete the anastomosis, typically in approximately one minute, and eliminate aortic clamping and manipulation, which greatly reduces the risk of particle release and ensuing neurocognitive events. The system also provides one-turn aortotomy and anastomosis, reducing the time required for the procedure, and producing consistent, reproducible results largely independent of surgical technique and skill set. The system also ensures secure graft attachment, allowing for variable take-off angles; leaves no metal within the graft lumen; and can be loaded into the system without damaging endothelial cells while maximizing the orifice, especially important in small grafts.

To complete a proximal anastomosis, the cardiac surgeon loads the bypass graft vessel into the PAS-Port system, places the end of the delivery device against the aorta and turns the knob on the opposite end of the delivery tool. The device first creates an opening in the aorta and subsequently securely attaches the bypass graft to the aortic wall, using a medical grade stainless steel implant that is formed into its final shape by the delivery tool. The system allows the surgeon to load the bypass graft and complete the anastomosis in approximately three minutes, with little or no injury to the bypass graft vessel or the aorta. The PAS-Port system is a product of Cardica (Redwood City, CA, USA), and has been approved by the U.S. Food and Drug Administration (FDA). The system is also approved for sale and marketed in the European Community and in Japan.

"The PAS-Port system is associated with significant patient benefits compared with hand-sewn anastomoses,” said John Puskas, M.D., of Emory University (Atlanta, GA, USA). "Because the PAS-Port device can be used to create a proximal anastomosis without needing to clamp the aorta, it may ultimately improve patient outcomes by shortening surgery times and hospital stays and reducing complications associated with aortic clamping.”

Related Links:
Cardica
Emory University


Gold Member
12-Channel ECG
CM1200B
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Floor‑Mounted Digital X‑Ray System
MasteRad MX30+
Half Apron
Demi
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.